The Journal of Arthroplasty
Volume 18, Issue 3 , Pages 352-360 , April 2003

The application potential of sintered β-dicalcium pyrophosphate in total joint arthroplasty

  • Jui-Sheng Sun, MD, PhD

      Affiliations

    • Department of Biomedical Engineering
    • Department of Orthopedic Surgery, National Taiwan University Hospital, Taipei
  • ,
  • Yang-Hwei Tsuang, MD, PhD

      Affiliations

    • Department of Orthopedic Surgery, China Medical College Hospital, Taichung
  • ,
  • Feng-Huei Lin, PhD

      Affiliations

    • Department of Biomedical Engineering
    • Institutes of Biomedical Engineering, National Taiwan University, Taipei, Taiwan, ROC
  • ,
  • Li-Ting Chen, BS

      Affiliations

    • Department of Orthopedic Surgery, National Taiwan University Hospital, Taipei
  • ,
  • Yi-Shiong Hang, MD

      Affiliations

    • Department of Orthopedic Surgery, National Taiwan University Hospital, Taipei
  • ,
  • Hwa-Chang Liu, MD, PhD

      Affiliations

    • Department of Orthopedic Surgery, National Taiwan University Hospital, Taipei

Received 28 February 2000 ,Accepted 8 October 2002.

References 

  1. Jarcho M. Calcium phosphates as ceramics as hard tissue prosthetics. Clin Orthop. 1981;157:259
  2. Hupp JR, McKenna SJ. Use of porous hydroxyapatite blocks for augmentation of atrophic mandibles. J Oral Maxillofac Surg. 1988;46:533
  3. Ducheyne P. Bioceramics: material characteristics versus in vivo behavior. J Biomed Mater Res. 1987;21(Suppl A2):219
  4. Lin FH, Lin CC, Lu CM, et al.  Mechanical properties and histological evaluation of sintered beta-Ca2P2O7 with Na4P2O7•10H2O addition. Biomaterials. 1995;16:793
  5. Lin CC, Liao CJ, Sun JS, et al.  Prevascularized bone graft cultured in sintered porous beta-Ca2P2O7 with 5 wt% Na4P2O7•10H2O addition ceramic chamber. Biomaterials. 1996;17:1133
  6. Whillert HG, Semlitch M. Reactions of the articular capsule to wear products of artificial prosthesis. J Biomed Mater Res. 1977;11:157
  7. Evans EJ. Cell damage in vitro following direct contact with fine particles of titanium, titanium alloy and cobalt-chrome-molybdenum alloy. Biomaterials. 1994;15:713
  8. Sun JS, Tsuang YH, Liao CJ, et al.  The effects of calcium phosphates particles on the growth of osteoblast. J Biomed Mater Res. 1997;37:324
  9. Sun JS, Lin FH, Hung TY, et al.  The influence of hydroxyapatite particles on osteoclasts cell activities. J Biomed Mater Res. 1999;45:311
  10. Tanaka S, Takahashi N, Udagawa N, et al.  Macrophage coclony-stimulating factor is indepensable for both proliferation and differentiation of osteoclast progenitors. J Clin Invest. 1993;91:257
  11. Takahashi N, Akatsu T, Udagawa N, et al.  Osteoblastic cells are involved in osteoclast formation. Endocrinology. 1988;123:2600
  12. Sun JS, Liu HC, Chang WHS, et al.  The influence of hydroxyapatite particle size on bone cell activities: an in vitro study. J Biomed Mater Res. 1998;39:390
  13. Bos GD, Goldberg VM, Zika JM, et al.  Immune response of rats to frozen bone allografts. J Bone Joint Surg Am. 1983;65:239
  14. Hollinger JO, Battisone GC. Biodegradable bone repair materials: synthetic polymers and ceramics. Clin Orthop. 1986;207:290
  15. Mankin HJ, Gebhardt MC, Tomford WW. The use of frozen cadaveric allografts in the management of patients with bone tumors of the extremities. Orthop Clin North Am. 1987;18:275
  16. Urist MR, Dawson E. Intertransverse process fusion with aid of chemosterilized autolyzed antigen-extracted allogeneic (AAA) bone. Clin Orthop. 1981;154:97
  17. Clark AE, Hench LL, Paschall HA. The influence of surface chemistry on implant interface histology: a theoretical basis for implant material selection. J Biomed Mater Res. 1976;10:161
  18. In: Toxicity of ceramics.  Williams DF editors. The fundamental aspect of biocompatibility. Boca Raton: CRC Press,; 1981;p. 87
  19. Gregoire M, Orly I, Menanteau J. The influence of calcium phosphate biomaterials on human bone cell activities: an in vitro approach. J Biomed Mater Res. 1990;24:165
  20. Maloney WJ, Smith RL. Periprosthetic osteolysis in total hip arthroplasty: the role of particulate wear debris. J Bone Joint Surg Am. 1995;77:1448
  21. Ballock RT, Roberts AB. Growth factors: a practical approach. In:  McKay I,  Leigh I editor. Growth factors: a practical approach. Oxford: Oxford University Press,; 1993;p. 95
  22. Sun JS, Tsuang YH, Liao CJ, et al.  The effect of sintered β-dicalcium pyrophosphate particle size on newborn Wistar rats osteoblasts. Artif Organs. 1999;23:331
  23. Cheung HA, Haak MH. Growth of osteoblasts on porous calcium phosphate ceramic: an in vitro model for biocompatibility study. Biomaterials. 1989;10:63
  24. Evans EJ, Clarke-Smith EMH. Studies on the mechanism of cell damage by finely ground hydroxyapatite particles in vitro. Clin Mater. 1991;7:241
  25. Lerner UH, Ransjo M, Ljunggren O. Prostaglandin E2 causes a transient inhibition of mineral mobilization, matrix degradation, and lysosomal enzyme release from mouse calvarial bones in vitro. Calcif Tissue Int. 1987;40:323
  26. Klein DC, Raisz LG. Prostaglandins: stimulation of bone resorption in tissue culture. Endocrinology. 1970;86:1436
  27. Schelling SH, Wolfe HJ, Tashjian AH. Role of the osteoclast in prostaglandin E2-stimulated bone resorption: a correlative morphometric and biochemical analysis. Lab Invest. 1980;42:290
  28. Tashjian AH, Voelkel EF, Lazzaro M, et al.  Tumor necrosis factor-alpha (cachectin) stimulates bone resorption in mouse calvaria via a prostaglandin-mediated mechanism. Endocrinology. 1987;120:2029
  29. Santoro MG, Jaffe BM, Simmons DJ. Bone resorption in vitro and in vivo in PGE-treated mice. Proc Soc Exp Biol Med. 1977;156:373
  30. Desimone DP, Greene VS, Hannon KS, et al.  Prostaglandin E2 administered by subcutaneous pellets causes local inflammation and systemic bone loss: a model for inflammation-induced bone disease. J Bone Miner Res. 1993;8:625
  31. Chambers TJ, Ali NN. Inhibition of osteoclastic motility by prostaglandins I2, E1, E2 and 6-oxo-E1. J Pathol. 1983;139:383
  32. Chambers TJ, McSheehy PM, Thomson BM, Fuller K. The effect of calcium-regulating hormones and prostaglandins on bone resorption by osteoclasts disaggregated from neonatal rabbit bones. Endocrinology. 1985;116:234
  33. Fuller K, Chambers TJ. Effect of arachidonic acid metabolites on bone resorption by isolated rat osteoclasts. J Bone Miner Res. 1989;4:209
  34. Collins DA, Chambers TJ. Effect of prostaglendins E1, E2, F on osteoclast formation in mouse bone marrow cultures. J Bone Miner Res. 1991;6:157
  35. Okuda A, Taylor LM, Heersche JN. Prostaglandin E2 initially inhibits and then stimulates bone resorption in isolated rabbit osteoclast cultures. J Bone Miner Res. 1989;7:255
  36. Collins DA, Chambers TJ. Prostaglandin E2 promotes osteoclast formation in murine hematopoietic cultures through an action on hematopoietic cells. J Bone Miner Res. 1992;7:555
  37. Quinn JMW, Sabokbar A, Denne M, et al.  Inhibitory and stimulatory effects of prostaglandins on osteoclast differentiation. Calcif Tissue Int. 1997;60:63
  38. Khosla S. Minireview: the OPG/RANKL/RANK system. Endocrinology. 2001;142:5050
  39. O'Brien EA, Williams JH, Marshall MJ. Osteoprotegerin is produced when prostaglandin synthesis is inhibited causing osteoclasts to detach from the surface of mouse parietal bone and attach to the endocranial membrane. Bone. 2001;28:208
  40. Chikazu D, Katagiri M, Ogasawara T, et al.  Regulation of osteoclast differentiation by fibroblast growth factor 2: stimulation of receptor activator of nuclear factor kappaB ligand/osteoclast differentiation factor expression in osteoblasts and inhibition of macrophage colony-stimulating factor function in osteoclast precursors. J Bone Miner Res. 2001;16:2074

 Funds were received from the National Science Council, ROC, in support of the research material described in this study.

☆☆ Reprint requests: Feng-Huei Lin, PhD, Institute of Biomedical Engineering, National Taiwan University, No 1, Jen-Ai Road, Taipei, Taiwan, ROC.

 0883-5403/03/1803-0018$30.00/0

PII: S0883-5403(02)06255-1

doi: 10.1054/arth.2003.50054

The Journal of Arthroplasty
Volume 18, Issue 3 , Pages 352-360 , April 2003